For example, the increased PKM2 expression was associated with later stage and lymph metastasis of the colorectal cancer cells, which also promoted the oxaliplatin resistance [29–30]; In HCC, the PKM2 also promoted metastasis by recruiting the myeloid-derived suppressor cells and indicated poor prognosis [31]. This evidence concerns the gene PKM and colorectal cancer.